These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21674060)
1. Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors. Cai C; Che J; Xu L; Guo Q; Kong Y; Fu L; Xu J; Cheng Y; Chen W PLoS One; 2011; 6(6):e20646. PubMed ID: 21674060 [TBL] [Abstract][Full Text] [Related]
2. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor. Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881 [TBL] [Abstract][Full Text] [Related]
3. The receptors that mediate the direct lethality of anthrax toxin. Liu S; Zhang Y; Hoover B; Leppla SH Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637 [TBL] [Abstract][Full Text] [Related]
4. A soluble receptor decoy protects rats against anthrax lethal toxin challenge. Scobie HM; Thomas D; Marlett JM; Destito G; Wigelsworth DJ; Collier RJ; Young JA; Manchester M J Infect Dis; 2005 Sep; 192(6):1047-51. PubMed ID: 16107958 [TBL] [Abstract][Full Text] [Related]
5. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532 [TBL] [Abstract][Full Text] [Related]
6. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting. Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325 [TBL] [Abstract][Full Text] [Related]
7. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Scobie HM; Rainey GJ; Bradley KA; Young JA Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348 [TBL] [Abstract][Full Text] [Related]
8. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells. Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181 [TBL] [Abstract][Full Text] [Related]
9. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin. Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457 [TBL] [Abstract][Full Text] [Related]
10. Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice. de Oliveira FFM; Mamillapalli S; Gonti S; Brey RN; Li H; Schiffer J; Casadevall A; Bann JG mSphere; 2020 Jan; 5(1):. PubMed ID: 31941807 [TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1. Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026 [TBL] [Abstract][Full Text] [Related]
12. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability. Mamillapalli S; Miyagi M; Bann JG Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231 [TBL] [Abstract][Full Text] [Related]
13. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490 [TBL] [Abstract][Full Text] [Related]
14. Targeted silencing of anthrax toxin receptors protects against anthrax toxins. Arévalo MT; Navarro A; Arico CD; Li J; Alkhatib O; Chen S; Diaz-Arévalo D; Zeng M J Biol Chem; 2014 May; 289(22):15730-8. PubMed ID: 24742682 [TBL] [Abstract][Full Text] [Related]
15. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2. Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508 [TBL] [Abstract][Full Text] [Related]
16. Interactions between anthrax toxin receptors and protective antigen. Scobie HM; Young JA Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864 [TBL] [Abstract][Full Text] [Related]
17. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin. Martchenko M; Jeong SY; Cohen SN Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. Lacy DB; Wigelsworth DJ; Scobie HM; Young JA; Collier RJ Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6367-72. PubMed ID: 15079089 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the interaction between anthrax toxin and its cellular receptors. Liu S; Leung HJ; Leppla SH Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430 [TBL] [Abstract][Full Text] [Related]
20. Expression and purification of functional human anthrax toxin receptor (ATR/TEM8) binding domain from Escherichia coli. Ding Z; Bradley KA; Amin Arnaout M; Xiong JP Protein Expr Purif; 2006 Sep; 49(1):121-8. PubMed ID: 16798009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]